Department of Orthopaedic Surgery, Baerum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.
Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway.
Bone Joint J. 2020 Feb;102-B(2):212-219. doi: 10.1302/0301-620X.102B2.BJJ-2019-0692.R2.
In a randomized controlled trial with two-year follow-up, patients treated with suture button (SB) for acute syndesmotic injury had better outcomes than patients treated with syndesmotic screw (SS). The aim of this study was to compare clinical and radiological outcomes for these treatment groups after five years.
A total of 97 patients with acute syndesmotic injury were randomized to SS or SB. The five-year follow-up rate was 81 patients (84%). The primary outcome was the American Orthopaedic Foot and Ankle Society (AOFAS) Ankle Hindfoot Scale. Secondary outcome measures included Olerud-Molander Ankle (OMA) score, visual analogue scale (VAS), EuroQol five-dimension questionnaire (EQ-5D), range of movement, complications, reoperations, and radiological results. CT scans of both ankles were obtained after surgery, and after one, two, and five years.
The SB group had higher median AOFAS score (100 (interquartile range (IQR) 92 to 100) vs 90 (IQR 85 to 100); p = 0.006) and higher median OMA score (100 (IQR 95 to 100) vs 95 (IQR 75 to 100); p = 0.006). The SS group had a higher incidence of ankle osteoarthritis (OA) (24 (65%) vs 14 (35%), odds ratio (OR) 3.4 (95% confidence interval (CI) 1.3 to 8.8); p = 0.009). On axial CT we measured a significantly smaller mean difference in the anterior tibiofibular distance between injured and non-injured ankles in the SB group (-0.1 mm vs 1.2 mm; p = 0.016).
Five years after syndesmotic injury treated with either SB or SS, we found better AOFAS and OMA scores, and lower incidence of ankle OA, in the SB group. These long-term results favour the use of SB when treating an acute syndesmotic injury. Cite this article: 2020;102-B(2):212-219.
在一项为期两年的随机对照试验中,接受缝线纽扣(SB)治疗的急性下胫腓联合损伤患者的治疗结果优于接受下胫腓螺钉(SS)治疗的患者。本研究的目的是比较这两组患者在五年后的临床和影像学结果。
共有 97 例急性下胫腓联合损伤患者被随机分为 SS 或 SB 组。五年随访率为 81 例患者(84%)。主要结局指标是美国矫形足踝协会(AOFAS)踝后足评分。次要结局指标包括 Olerud-Molander 踝关节(OMA)评分、视觉模拟评分(VAS)、欧洲五维健康量表(EQ-5D)、活动范围、并发症、再手术和影像学结果。术后、术后 1、2 和 5 年,对双侧踝关节进行 CT 扫描。
SB 组的 AOFAS 评分中位数较高(100(四分位距(IQR)92 至 100)比 90(IQR 85 至 100);p = 0.006),OMA 评分中位数也较高(100(IQR 95 至 100)比 95(IQR 75 至 100);p = 0.006)。SS 组踝关节骨关节炎(OA)的发生率较高(24 例(65%)比 14 例(35%),优势比(OR)3.4(95%置信区间(CI)1.3 至 8.8);p = 0.009)。在轴位 CT 上,我们测量到 SB 组受伤和未受伤踝关节间前胫腓间距的平均差异明显较小(-0.1 毫米比 1.2 毫米;p = 0.016)。
在下胫腓联合损伤后五年,接受 SB 或 SS 治疗的患者中,SB 组的 AOFAS 和 OMA 评分更好,踝关节 OA 的发生率更低。这些长期结果表明,在治疗急性下胫腓联合损伤时,应优先使用 SB。